Qube Research & Technologies (QRT)
ALBO

Qube Research & Technologies (QRT)’s Albireo Pharma Inc ALBO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-54,015
Closed -$1.07M – 3217
2022
Q2 		$1.07M Buy
+54,015
New +$1.42M 0.01% 1077
2020
Q4 		– Sell
-12,047
Closed -$402K – 2308
2020
Q3 		$402K Buy
+12,047
New +$351K 0.01% 1118

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALBO Position: Q3 2022 in Review

Qube Research & Technologies (QRT) sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 54,015 shares — an estimated $1.07M sold.

Qube Research & Technologies (QRT) first reported a position in ALBO in Q3 2020 and held it in 2 quarters. The position peaked at $1.07M in Q2 2022. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Qube Research & Technologies (QRT) reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 54,015 Albireo Pharma Inc shares in Q3 2022, an estimated $1.07M.
  • Qube Research & Technologies (QRT) first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Albireo Pharma Inc position peaked at $1.07M in Q2 2022.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.